Boston Scientific (BSX) FY2022 results: revenue $12.7 billion, up 6.7% on the year
Boston Scientific Corp. (BSX) reported revenue of $12.7 billion for fiscal 2022, the year ended 31 December 2022, up 6.7% on the year before. Net income was $642 million, down 34.8%, and diluted earnings per share $0.45. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2023.
Revenue
$12.7 billion
+6.7% on the year
FY2015FY2022
Operating margin
13.0%
10.1% a year earlier
FY2015FY2022
Net income
$642 million
-34.8% on the year
FY2015FY2022
Diluted EPS
$0.45
-34.8% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
1,526
1,870
1,508
-18.4%
Capital expenditure
588
554
376
+6.1%
Free cash flow
938
1,316
1,132
-28.7%
Free cash flow margin
7.4%
11.1%
11.4%
Cash from investing
-2,011
-1,597
-411
Cash from financing
-548
-95.0
293
Depreciation and amortisation
1,136
1,093
1,123
+3.9%
Share-based compensation
220
194
170
+13.4%
Buybacks
0.0
0.0
535
Dividends paid
55.0
55.0
28.0
0.0%
Diluted shares, weighted
1,440m
1,434m
1,417m
+0.4%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
17,573
16,622
15,326
+5.7%
Non-controlling interest
0.0
n/a
n/a
Debt
8,915
9,065
9,130
-1.7%
Operating lease liabilities
347
389
401
-10.8%
Other liabilities
5,634
6,153
5,920
-8.4%
Total liabilities and equity
32,469
32,229
30,777
+0.7%
Fixed assets
2,446
2,252
2,084
+8.6%
Goodwill
12,920
11,988
9,951
+7.8%
Intangible assets
5,902
6,121
5,917
-3.6%
Securities held for sale or to maturity
1.0
0.0
2.0
Cash and equivalents
928
1,925
1,734
-51.8%
Inventory
1,867
1,610
1,351
+16.0%
Other assets
8,405
8,333
9,738
+0.9%
Total assets
32,469
32,229
30,777
+0.7%
10-K for the year ended 31 December 2022, filed 23 February 2023: the filing.